US Bancorp DE Has $4.34 Million Stock Position in Regeneron

US Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,941 shares of the biopharmaceutical company’s stock after acquiring an additional 310 shares during […]

Related Keywords

United States , Los Angeles , California , America , Andrewj Murphy , Arthurf Ryan , , Los Angeles Capital Management , Regeneron Pharmaceuticals Profile , News Ratings For Regeneron Pharmaceuticals Daily , Quarter For Regeneron Pharmaceuticals , Morgan Stanley , Savant Capital , Great Valley Advisor Group Inc , Securities Inc , Securities Exchange Commission , Regeneron Pharmaceuticals Inc , Exchange Commission , Regeneron Pharmaceuticals Stock Performance , Nasdaq , Wealthspire Advisors , Us Bancorp , Regeneron Pharmaceuticals , Free Report , Angeles Capital Management , Valley Advisor Group , Get Free Report , Director Arthur , Regeneron Pharmaceuticals Daily ,